These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29155963)

  • 1. Generating Modeling Data From Repeat-Dose Toxicity Reports.
    López-Massaguer O; Pinto-Gil K; Sanz F; Amberg A; Anger LT; Stolte M; Ravagli C; Marc P; Pastor M
    Toxicol Sci; 2018 Mar; 162(1):287-300. PubMed ID: 29155963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inroads to predict in vivo toxicology-an introduction to the eTOX Project.
    Briggs K; Cases M; Heard DJ; Pastor M; Pognan F; Sanz F; Schwab CH; Steger-Hartmann T; Sutter A; Watson DK; Wichard JD
    Int J Mol Sci; 2012; 13(3):3820-3846. PubMed ID: 22489185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Safety Assessment of Chemicals and Drug Candidates by the Integration of Bioinformatics and Chemoinformatics Data.
    Steger-Hartmann T; Pognan F
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():29-36. PubMed ID: 29316298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Zhu X; Kruhlak NL
    Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a unifying strategy for the structure-based prediction of toxicological endpoints.
    Carrió P; Sanz F; Pastor M
    Arch Toxicol; 2016 Oct; 90(10):2445-60. PubMed ID: 26553148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legacy data sharing to improve drug safety assessment: the eTOX project.
    Sanz F; Pognan F; Steger-Hartmann T; Díaz C; ; Cases M; Pastor M; Marc P; Wichard J; Briggs K; Watson DK; Kleinöder T; Yang C; Amberg A; Beaumont M; Brookes AJ; Brunak S; Cronin MTD; Ecker GF; Escher S; Greene N; Guzmán A; Hersey A; Jacques P; Lammens L; Mestres J; Muster W; Northeved H; Pinches M; Saiz J; Sajot N; Valencia A; van der Lei J; Vermeulen NPE; Vock E; Wolber G; Zamora I
    Nat Rev Drug Discov; 2017 Dec; 16(12):811-812. PubMed ID: 29026211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology.
    Bugelski PJ; Atif U; Molton S; Toeg I; Lord PG; Morgan DG
    Pharm Res; 2000 Oct; 17(10):1265-72. PubMed ID: 11145233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing the concept of virtual control groups into preclinical toxicology testing.
    Steger-Hartmann T; Kreuchwig A; Vaas L; Wichard J; Bringezu F; Amberg A; Muster W; Pognan F; Barber C
    ALTEX; 2020; 37(3):343-349. PubMed ID: 32242633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned from pre-clinical juvenile toxicity studies?
    Bailey GP; Mariën D
    Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eTOX data-sharing project to advance in silico drug-induced toxicity prediction.
    Cases M; Briggs K; Steger-Hartmann T; Pognan F; Marc P; Kleinöder T; Schwab CH; Pastor M; Wichard J; Sanz F
    Int J Mol Sci; 2014 Nov; 15(11):21136-54. PubMed ID: 25405742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curation and analysis of clinical pathology parameters and histopathologic findings from eTOXsys, a large database project (eTOX) for toxicologic studies.
    Pinches MD; Thomas R; Porter R; Camidge L; Briggs K
    Regul Toxicol Pharmacol; 2019 Oct; 107():104396. PubMed ID: 31128168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.
    Basant N; Gupta S; Singh KP
    Regul Toxicol Pharmacol; 2016 Jun; 77():282-91. PubMed ID: 27018829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of molecular structures, endpoints' values, and predictivity parameters in QSAR research: QSAR analysis of a series of estrogen receptor binders.
    Li J; Gramatica P
    Mol Divers; 2010 Nov; 14(4):687-96. PubMed ID: 19921452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing a developmental and reproductive toxicity database of chemicals (DART NIHS DB) for integrated approaches to testing and assessment.
    Yamada T; Miura M; Kawamura T; Ushida K; Inoue K; Kuwagata M; Katsutani N; Hirose A
    J Toxicol Sci; 2021; 46(11):531-538. PubMed ID: 34719556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.